Commerzbank set a €112.00 ($130.23) price objective on Hannover Re (FRA:HNR1) in a report issued on Monday, May 28th. The firm currently has a neutral rating on the stock.

A number of other equities analysts have also commented on HNR1. DZ Bank reiterated a buy rating on shares of Hannover Re in a research note on Monday, May 7th. Independent Research set a €121.00 ($140.70) price objective on Hannover Re and gave the company a neutral rating in a report on Monday, May 7th. equinet set a €110.00 ($127.91) target price on Hannover Re and gave the stock a neutral rating in a report on Monday, May 7th. Societe Generale set a €107.00 ($124.42) target price on Hannover Re and gave the stock a neutral rating in a report on Monday, May 7th. Finally, Baader Bank set a €107.00 ($124.42) price objective on shares of Hannover Re and gave the stock a neutral rating in a research report on Monday, May 7th. Five equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and three have assigned a buy rating to the company’s stock. Hannover Re currently has an average rating of Hold and an average target price of €112.00 ($130.24).

Shares of HNR1 traded up €0.90 ($1.05) during trading hours on Monday, hitting €111.90 ($130.12). 166,978 shares of the company were exchanged. Hannover Re has a one year low of €94.75 ($110.17) and a one year high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.